Simple Summary The poor prognosis of pancreatic cancer (PC) is associated with several
factors, such as diagnosis at an advanced stage, early distant metastases, and remarkable …

Pancreatic cancer (PC) is an aggressive disease that is challenging to treat and is
associated with a high mortality rate. The most common type of PC is pancreatic ductal …

Oncogenic Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations are highly
prevalent in pancreatic ductal adenocarcinoma (PDAC) and have garnered attention as …

Pancreatic cancer remains one of the deadliest of all cancer types with a 5-year overall
survival rate of just 12%. Preclinical models available for understanding the disease …

Pancreatic cancer (PC) is the third-leading cause of cancer deaths. The overall 5-year
survival rate of PC is 9%, and this rate for metastatic PC is below 3%. However, the PC …

Lung cancer is the second most common cancer in the world, being the first cause of cancer-
related mortality. Surgery remains the only potentially curative treatment for Non-Small Cell …

This study aims to enhance the solubility of Olaparib, classified as biopharmaceutical
classification system (BCS) class IV due to its low solubility and bioavailability using a solid …

On the basis of remarkable anticancer profile of s‐triazine nucleus, a new series of 2‐
methoxy‐4‐(3‐morpholino‐5‐(arylamino) phenoxy) benzaldehyde derivatives 11 a–u was …

The recognition that DNA can be ADP-ribosylated has major consequences for our
understanding of how ADP-ribosylation (ADPr) contributes to genome stability, epigenetics …

Pancreatic cancer is the 10 th most common cancer diagnosis and 4 th most common cause
of cancer mortality in the United States, highlighting a disparity between disease prevalence …